Correction to: European Journal of Human Genetics https://doi.org/10.1038/s41431-019-0537-8, published online 21 November 2019
The following acknowledgement was missing from this article.
Two of several authors of this publication are members of the “European Reference Network rare kidney diseases ERKNet”.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Daga, S., Donati, F., Capitani, K. et al. Correction: New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells. Eur J Hum Genet 32, 131 (2024). https://doi.org/10.1038/s41431-023-01287-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-023-01287-y
